Tenderwize
Back to tender search

Open-house original rebate contracts: emtricitabine/tenofovir alafenamide/rilpivirine

Techniker Krankenkasse·Hamburg, Germany·Deadline Feb 27, 2027 · 193 days left·Open·Supplies
Original notice title

Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-04 - Emtricitabin/Tenofoviralafenamid/Rilpivirin (Odefsey(R))

0/100

Opportunity Score

High riskLow complexity
SuppliesOpen
Why this score?

Opportunity

0 / 100

Complexity

0 / 100

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Open House Originale Rabattverträge 2025-04 - Emtricitabin/Tenofoviralafenamid/Rilpivirin (Odefsey(R))

Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130c Abs. 1 SGB V zur Wirkstoffkombination Emtricitabin/Tenofoviralafenamid/Rilpivirin (Odefsey(R)) zu schließen.

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

Feb 2025 - Feb 2027

Category

Pharmaceutical products

Procurement Details

Publication date
20 Jan 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
39983-2025

Documents (1)

Similar tenders